Ex Parte TAN et al - Page 3




          Appeal No. 2002-1551                                                        
          Application No. 09/286,386                                                  


          claims stand rejected under 35 U.S.C. § 103 as being unpatentable           
          over Hwang in view of Amon.                                                 
               We consider first the examiner's double patenting rejection.           
          Although appellants contested this rejection in the principal               
          brief, appellants informed the Board that "a Terminal Disclaimer            
          will be filed to disclaim any patent term which extends beyond              
          the full term of U.S. Patent No. 5,883,043, such that Issue 1 set           
          forth in the Brief of Appeal will be moot" (page 1 of Reply                 
          Brief).  Accordingly, appellants now do not contest the                     
          examiner's double patenting rejection and we, per force, sustain            
          the examiner's rejection.                                                   
               We now turn to the examiner's rejection of the appealed                
          claims under § 103.  Having thoroughly reviewed the opposing                
          positions advanced by appellants and the examiner, we find                  
          ourselves in agreement with appellants that the examiner has not            
          established a prima facie case of obviousness for the claimed               
          subject matter.  Hwang, the primary reference, is directed to a             
          particular ink composition that comprises a mixture of infrared             
          absorptive dyestuffs and an alkaline agent.  As appreciated by              
          the examiner, Hwang does not teach the inclusion of the presently           
          claimed thermochromic, photochromic and fluorescent pigments and            
          dyes.  To remedy this deficiency, the examiner relies upon Amon             


                                         -3-                                          




Page:  Previous  1  2  3  4  5  6  7  Next 

Last modified: November 3, 2007